- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethyl
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride
| EU orphan designation number: | EU/3/15/1481
|
| Active ingredient: | Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride |
| Indication: | Treatment of Huntington’s disease |
| Sponsor: | Ipsen Pharma
65 quai Georges Gorse, F-92100 Boulogne-Billancourt, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 28/04/2015 | Orphan designation | EMA/OD/311/14 | (2015)2945 of 24/04/2015 |
CONTACT
EU links
Directorate General Health & Consumers